.Attributes Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective calls for addition of individuals along with MASLD and also size of liver outcomes in cardio-- kidney-- metabolic trials, when information recommend mechanistically conceivable advantages and also clinical security-- and lays out considerations for test design and also regulatory commendation.